mergers & acquisitions

Enicor's ClotPro system uses active tip technology, reduces the need for manual pipetting and eliminates reagent handling.

Of the 28 companies in the 360 Index, six companies' share prices increased while the share values of 22 declined month over month.

In addition, Biolidics entered a distribution agreement with Clearbridge Medical Group to distribute tests in multiple Asian countries and Australia. 

OpGen also reported full-year growth was driven by revenue increases for its Acuitas AMR Gene Panel and Acuitas Lighthouse informatics platform.

The company plans to use the net proceeds to pay in part for its anticipated acquisition of Qiagen, as well as for general corporate purposes.

Invitae said YouScript and Genelex will enable it to provide pharmacogenomic testing, while Diploid will help interpret WGS results.

AdGeniX started distributing Yourgene's Iona test in France in 2015 and has rapidly grown sales for the test, a trend that is expected to continue.

Thermo Fisher will pay €39 ($43.35) per share of Qiagen's stock, a premium of about 23 percent on the stock's closing price on the Frankfurt Prime Standard on March 2.

OpGen, which is acquiring Curetis, said that combined revenue for both companies would have been about $6 million in 2019 had the deal been completed last year.